Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Grundy RG"" wg kryterium: Autor


Tytuł:
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Autorzy:
Grundy RG (AUTHOR)
Wilne SA (AUTHOR)
Weston CL (AUTHOR)
Robinson K (AUTHOR)
Lashford LS (AUTHOR)
Ironside J (AUTHOR)
Cox T (AUTHOR)
Chong WK (AUTHOR)
Campbell RHA (AUTHOR)
Bailey CC (AUTHOR)
Gattamaneni R (AUTHOR)
Picton S (AUTHOR)
Thorpe N (AUTHOR)
Mallucci C (AUTHOR)
English MW (AUTHOR)
Punt JAG (AUTHOR)
Walker DA (AUTHOR)
Ellison DW (AUTHOR)
Machin D (AUTHOR)
Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee (CORPORATE AUTHOR)
Pokaż więcej
Źródło:
Lancet Oncology. Aug2007, Vol. 8 Issue 8, p696-705. 10p.
Czasopismo naukowe
Tytuł:
Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD).
Autorzy:
Briggs M; Department of Neuropathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Das A; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Firth H; Department of Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Levine A; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Sánchez-Ramírez S; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Negm L; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Ercan AB; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Chung J; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Bianchi V; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Jalloh I; Department of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Phyu P; Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Thorp N; Department of Radiation Oncology, The Christie Proton Beam Therapy Centre, Manchester, UK.
Grundy RG; Children's Brain Tumour Research Centre, Biodiscovery Unit, University of Nottingham, Nottingham, UK.
Hawkins C; Division of Neuropathology, The Hospital for Sick Children, Toronto, ON, Canada.
Trotman J; East-Genomics Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Tarpey P; East-Genomics Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Tabori U; The International Replication Repair Deficiency Consortium (IRRDC), Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Allinson K; Department of Neuropathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Murray MJ; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Pokaż więcej
Corporate Authors:
Genomics England Research Consortium
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2023 Feb; Vol. 49 (1), pp. e12862. Date of Electronic Publication: 2022 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplastic Syndromes, Hereditary*
Colorectal Neoplasms*
Brain Neoplasms*
Ependymoma*
Humans ; Child ; Mutation
SCR Disease Name:
Turcot syndrome
Czasopismo naukowe
Tytuł:
Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism.
Autorzy:
Wood J; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
Abdelrazig S; Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Evseev S; Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Ortori C; Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Castellanos-Uribe M; Nottingham Arabidopsis Stock Centre, School of Biosciences, University of Nottingham, Nottingham NG7 2RD, UK.
May ST; Nottingham Arabidopsis Stock Centre, School of Biosciences, University of Nottingham, Nottingham NG7 2RD, UK.
Barrett DA; Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Diksin M; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
Chakraborty S; Department of Biochemistry, University of Dhaka, Dhaka 1000, Bangladesh.
Kim DH; Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Grundy RG; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
Rahman R; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Aug 11; Vol. 14 (16). Date of Electronic Publication: 2022 Aug 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion.
Autorzy:
Bishop E; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.
Dimitrova M; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.
Froggatt A; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.
Estevez-Cebrero M; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.
Storer LCD; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.
Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Paine S; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Grundy RG; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Dandapani M; Childrens Brain Tumour Research Centre, School of Medicine, University of Nottingham, UK.; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Jun 22; Vol. 2022, pp. 9008685. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/genetics
Cerebellar Neoplasms*
Glioma*/genetics
Medulloblastoma*
Adult ; Arginase/genetics ; Arginine ; Argininosuccinate Lyase ; Child ; Ependymoma ; Humans ; Ornithine Carbamoyltransferase
SCR Disease Name:
Familial ependymoma
Czasopismo naukowe
Tytuł:
The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults.
Autorzy:
Mohammed OJ; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Cebrero ME; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Ahmad O; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Peet A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2SY, UK.; Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham B15 2TG, UK.
Grundy RG; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Lourdusamy A; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Jan 05; Vol. 14 (1). Date of Electronic Publication: 2022 Jan 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma.
Autorzy:
Sabnis DH; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Liu JF; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Simmonds L; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Blackburn S; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Grundy RG; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Kerr ID; School of Life Sciences, QMC, University of Nottingham, Nottingham NG7 2UH, UK.
Coyle B; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham NG7 2RD, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Apr 27; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 27.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies